Top 10 Global Pharmaceutical Company Awards $2.3 Million in Studies to eResearchTechnology for Cardiac Safety Monitoring and Inf
June 13 2005 - 9:22AM
PR Newswire (US)
Top 10 Global Pharmaceutical Company Awards $2.3 Million in Studies
to eResearchTechnology for Cardiac Safety Monitoring and
Information Distribution Services Phase III Program Award
Consistent with Recent ICH, E14 Implementation Guidance and
Reinforces Importance of Cardiac Safety Monitoring in Later Phase
Clinical Development PHILADELPHIA, June 13 /PRNewswire-FirstCall/
-- eResearchTechnology, Inc. (eRT), (NASDAQ:ERES), a leading
provider of centralized electrocardiographic (ECG) collection and
interpretation services, announced today that it has been awarded
more than $2.3 million in cardiac safety monitoring and services
from a top 10 global pharmaceutical organization for one of its key
drug candidates in late phase clinical trials. The award for the
Phase III program is comprised of a number of studies with an
investigator network that spans three continents. eRT will provide
comprehensive support, including provision of 270 units of digital
12-lead ECG equipment designed to facilitate collection of cardiac
safety data that is subsequently provided to eRT for analysis. eRT
will perform digital collection, measurement, interpretation,
review, and distribution of cardiac safety data through its
EXPeRT(R) workflow enabled data handling technology, the first
solution in production that was designed explicitly to meet
emerging international regulatory guidance and technical standards.
"We are pleased that the ICH committee ratified implementation
(step 4) of the E14 cardiac safety monitoring guidance that
reinforces cardiac safety monitoring in all phases of clinical
development. This contract represents an example of large
pharmaceutical company adopting the principles in the most recent
guidance document," said Scott Grisanti, senior vice president of
business development and chief marketing officer at eRT. "In
addition to experience with this compound, eRT's equipment
marshalling and logistics capabilities, along with extensive site
support and comprehensive project management, were important
factors in the sponsor's decision process." Based in Philadelphia,
PA, eResearchTechnology, Inc. ( http://www.ert.com/ ) is a provider
of technology and services to the pharmaceutical, biotechnology and
medical device industries on a global basis. The company is a
market leader in providing centralized core-diagnostic
electrocardiographic (ECG) technology and services to evaluate
cardiac safety in clinical development. The company is also a
leader in providing technology and services to streamline the
clinical trials process by enabling its customers to automate the
collection, analysis, and distribution of clinical data in all
phases of clinical development. Statements included in this release
may constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
involve a number of risks and uncertainties such as competitive
factors, technological development, market demand, and the
company's ability to obtain new contracts and accurately estimate
net revenues due to variability in size, scope and duration of
projects, and internal issues in the sponsoring client. The sponsor
may cancel this agreement at its sole discretion. As a result,
actual results may differ materially from any financial outlooks
stated herein. Further information on potential factors that could
affect the company's financial results can be found in the
company's Reports on Forms 10-K and 10-Q filed with the Securities
and Exchange Commission. DATASOURCE: eResearchTechnology, Inc.
CONTACT: Joan Sterlacci of eResearchTechnology, Inc.,
+1-908-203-6473; or Matt Hayden of Hayden Communications,
+1-858-704-5065 Web site: http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Tech (MM) News Articles